Myomo (NYSE: MYO) CEO granted 11,637 RSUs for salary deferral program

Rhea-AI Filing Summary

Myomo, Inc. reported that Chief Executive Officer and director Paul R. Gudonis received a grant of 11,637 shares of common stock on January 12, 2026 at a price of $0 per share. After this grant, he beneficially owned 1,260,650 shares of Myomo common stock in direct form.

The shares represent Restricted Stock Units under a Board-approved program that allows employees to forego 10% of their salary in exchange for RSUs with a grant date fair value of 115% of the salary exchanged. This particular grant covers three months of salary, and the RSUs vest in full on April 12, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GUDONIS PAUL R

(Last) (First) (Middle)

C/O MYOMO, INC.

45 BLUE SKY DR., SUITE 101

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/12/2026		A		11,637(1)	A	$0	1,260,650	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing exployees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on April 12, 2026.

	/s/ David A. Henry, Attorney-in-Fact	01/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Myomo (MYO) report for its CEO?

Myomo reported that Chief Executive Officer and director Paul R. Gudonis received a grant of 11,637 shares of common stock on January 12, 2026 at a price of $0 per share.

How many Myomo (MYO) shares does the CEO own after this transaction?

Following the grant, CEO Paul R. Gudonis beneficially owned 1,260,650 shares of Myomo, Inc. common stock, held in direct ownership.

What is the structure of the Myomo (MYO) salary exchange RSU program?

Under the Board-approved program, employees may forego 10% of their salary in exchange for Restricted Stock Units with a grant date fair value equal to 115% of the salary exchanged.

What period of salary does this Myomo (MYO) RSU grant cover?

The reported RSU grant covering 11,637 shares reflects the exchange of three months of salary under the company’s salary-for-RSU program.

When do the granted RSUs to the Myomo (MYO) CEO vest?

The Restricted Stock Units granted to CEO Paul R. Gudonis under this program vest in their entirety on April 12, 2026.

Did the Myomo (MYO) CEO pay cash for the 11,637-share grant?

The Form 4 shows a transaction price of $0 per share for the 11,637 shares, with the grant provided in exchange for foregone salary under the RSU program.